Billionaire Ken Fisher Loads Up on These 2 ‘Strong Buy’ Stocks

Investors looking for a guiding hand to steer them safely through the current hazardous stock market landscape could do worse than listen to what billionaire Ken Fisher has to say. The Fisher... Read more »

Stagflation Will Rule 2023, Keeping Stocks in Peril

(Bloomberg) — Stagflation is the key risk for the global economy in 2023, according to investors who said hopes of a rally in markets are premature following this year’s brutal selloff. Most... Read more »

Bearish Bets: A Defense Giant and 2 Other Stocks You Should Consider Shorting

Each week we identify names that look bearish and may present interesting investing opportunities on the short side. Using technical analysis of the charts of those stocks, and, when appropriate, recent actions... Read more »

Stocks, China Assets Face Rough Open as Covid Unrest Hits Mood

(Bloomberg) — Protests against China’s Covid curbs may cast a shadow on the nation’s assets and broader risk sentiment in global markets as trading resumes after the weekend. Most Read from Bloomberg... Read more »

Hot Biotech Stocks Lift Into Leadership; Pass Buy Points Or Build Bases Separator Site title Separator Site title

Hot biotech stock leaders are surging within the IBD 50 elite list, with some passing buy points and others building bases. Among them, Catalyst Pharmaceuticals (CPRX), Harmony Biosciences (HRMY), Genmab (GMAB) and... Read more »